Potentially causal associations between placental DNA methylation and schizophrenia and other neuropsychiatric disorders
Ariadna Cilleros‐Portet, Corina Lesseur, Sergi Marí, Marta Cosín‐Tomás, Manuel Lozano, Amaia Irizar, Amber Burt, Iraia García‐Santisteban, Diego Garrido-Martín, Geòrgia Escaramís, Alba Hernangomez‐Laderas, Raquel Soler-Blasco, Charles E. Breeze, Bárbara P. González‐García, Loreto Santa‐Marina, , Nora Fernández‐Jiménez
The paper identifies placental DNA methylation (DNAm) as a potential mediator of genetic risk for schizophrenia, bipolar disorder, and major depressive disorder using mQTL and GWAS data.
Nature Communications · Mar 14, 2025Peer-reviewedGenetic & Genomic Medicine